Digoxin, a medication that has been used to treat heart failure, may be adaptable for the treatment of amyotrophic lateral sclerosis (ALS), a progressive, paralyzing disease, suggests new research at the School of Medicine.
New research provides an intriguing glimpse into the processes that establish connections between nerve cells in the brain. These connections, or synapses, allow nerve cells to transmit and process information involved in thinking and moving the body. Pictured is the study’s senior author, Azad Bonni, MD, PhD.
Veteran physician Cheri LeBlanc, MD, has been treating patients during one of life’s most critical periods — the college years. As the new director of student health and wellness, LeBlanc hopes to educate students in ways that will last a lifetime.
A rare, inherited form of mental retardation has led scientists at the School of Medicine to three important “travel agents” at work in the developing brain. The agents make it possible for brain neurons to travel from where they are born to other brain regions where they will permanently reside.